Journal of Clinical and Experimental Ophthalmology
Open Access

Abstract

Use of Intravitreal Dexamethasone Implant (Ozurdex) Prior to Cataract Surgery in Uveitic Patients

Nur Azem, Raz Gepstein and Shiri Shulman

Purpose: To report the effect of preoperative use of Ozurdex implant, as a prophylactic treatment to cataract surgery in 5 patients with chronic uveitis.

Methods: A retrospective case reports.

Results: 5 patients with chronic uveitis were included in this study. All patients were treated with Ozurdex prior to cataract surgery. Patients showed significant improvement in visual acuity one month post-surgery and no recurrence of uveitis up to three months post-surgery. Only two patients showed recurrence of CME 3-4 months post Ozurdex injection, which is attributed to Ozurdex maximal effect as was shown in previous studies.

Conclusions: Intravitreal Ozurdex may serve as a perioperative anti-inflammatory treatment for uveitic patients undergoing cataract surgery.